The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2025

Filed:

Sep. 26, 2019
Applicant:

Voyager Therapeutics, Inc., Lexington, MA (US);

Inventors:

Holger Patzke, Lexington, MA (US);

Jinzhao Hou, Lexington, MA (US);

Hongxing Wang, Lexington, MA (US);

Yanqun Shu, Lexington, MA (US);

Martin Goulet, Lexington, MA (US);

Dinah Wen-Yee Sah, Lexington, MA (US);

Assignee:

Voyager Therapeutics, Inc., Lexington, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2005.12); A61K 47/02 (2005.12); A61K 47/10 (2016.12); A61K 48/00 (2005.12); C07K 14/47 (2005.12);
U.S. Cl.
CPC ...
C12N 15/86 (2012.12); A61K 47/02 (2012.12); A61K 47/10 (2012.12); A61K 48/005 (2012.12); C07K 14/47 (2012.12); C12N 2830/008 (2012.12);
Abstract

The disclosure relates to compositions and methods for altering, e.g., enhancing, the expression of frataxin (FXN), whether in vitro and/or in vivo including, but not limited to, the exploitation of engineered promoters. Such compositions include delivery via administration of an adeno-associated viral (AAV) particle. The compositions and methods of the present disclosure are useful in the treatment of subjects diagnosed with, or suspected of having Friedreich's ataxia or another neuromuscular or neurological condition resulting from a deficiency in the quantity and/or function of frataxin or associated with decreased expression or protein levels of frataxin.


Find Patent Forward Citations

Loading…